Literature DB >> 12421910

Cutting edge: persistent viral infection prevents tolerance induction and escapes immune control following CD28/CD40 blockade-based regimen.

Matthew A Williams1, Thandi M Onami, Andrew B Adams, Megan M Durham, Thomas C Pearson, Rafi Ahmed, Christian P Larsen.   

Abstract

A continuing concern with CD28 and/or CD40 blockade-based strategies to induce tolerance and mixed chimerism is their potential to disrupt protective immunity to preexisting infections. In this report, we find that preexisting persistent infection with lymphocytic choriomeningitis virus (LCMV) clone 13 prevents the induction of tolerance, mixed chimerism, and donor-reactive T cell deletion. Mice continue to be refractory to tolerance induction even after viremia has been resolved and virus is present only at very low levels in peripheral tissues. Conversely, we find that the full tolerance regimen, or costimulation blockade alone, specifically inhibits already ongoing antiviral immune responses, leading to an inability to control viremia. These findings suggest that ongoing T cell responses continue to depend on costimulatory interactions in the setting of a chronic infection and provide insight into potential risks following costimulation blockade posed by chronic or latent viral infections such as hepatitis C, EBV, and CMV.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12421910     DOI: 10.4049/jimmunol.169.10.5387

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

Review 1.  Heterologous immunity between viruses.

Authors:  Raymond M Welsh; Jenny W Che; Michael A Brehm; Liisa K Selin
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

Review 2.  T-cell activation and transplantation tolerance.

Authors:  Bhavana Priyadharshini; Dale L Greiner; Michael A Brehm
Journal:  Transplant Rev (Orlando)       Date:  2011-11-08       Impact factor: 3.943

Review 3.  Memory CD8 T-cell differentiation during viral infection.

Authors:  E John Wherry; Rafi Ahmed
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

Review 4.  Transplantation tolerance through mixed chimerism.

Authors:  Nina Pilat; Thomas Wekerle
Journal:  Nat Rev Nephrol       Date:  2010-08-31       Impact factor: 28.314

5.  Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression.

Authors:  D J Lo; T A Weaver; L Stempora; A K Mehta; M L Ford; C P Larsen; A D Kirk
Journal:  Am J Transplant       Date:  2010-11-10       Impact factor: 8.086

Review 6.  Homeostatic T cell proliferation as a barrier to T cell tolerance.

Authors:  Somia P Hickman; Laurence A Turka
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

Review 7.  Lung transplantation: opportunities for research and clinical advancement.

Authors:  David S Wilkes; Thomas M Egan; Herbert Y Reynolds
Journal:  Am J Respir Crit Care Med       Date:  2005-07-14       Impact factor: 21.405

8.  Cytotoxic herpes simplex type 2-specific, DQ0602-restricted CD4 T+-cell clones show alloreactivity to DQ0601.

Authors:  Sandra Reichstetter; Nathan E Standifer; Kelly A Geubtner; Andrew W Liu; Stacy L Agar; William W Kwok
Journal:  Immunology       Date:  2006-03       Impact factor: 7.397

Review 9.  Recent progress and new perspectives in studying T cell responses to allografts.

Authors:  A Valujskikh; W M Baldwin; R L Fairchild
Journal:  Am J Transplant       Date:  2010-03-26       Impact factor: 8.086

10.  Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs.

Authors:  Lesley A Smyth; Kulachelvy Ratnasothy; Aurelie Moreau; Sally Alcock; Pervinder Sagoo; Lucy Meader; Yakup Tanriver; Matthew Buckland; Robert Lechler; Giovanna Lombardi
Journal:  J Immunol       Date:  2013-03-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.